RxDoctor Payments Data

Asif Iqbal

Hematology & Oncology · Toledo, OHNPI 1174907737

Payments from drug & device makers

$343in general payments, 2019–2025

Across 11 payments — averaging $31.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$146
  • Johnson & Johnson$103
  • Stemline Therapeutics Inc.$38
  • AbbVie$24
  • Merck$18
  • Novartis$14

What the payments were for

  • Food & beverage$343100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$146
Johnson & Johnson(2 entities)5$103
Stemline Therapeutics Inc.2$38
AbbVie1$24
Merck1$18
Novartis1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$343 in reported general payments places this provider in the 15th percentile of 450 hematology & oncology providers in Ohio.

See all hematology & oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$108,883
Medicare patients
472
Services billed
1,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Midodrine Hcl11$1,620
Bumetanide17$610
Cefdinir44$422
Pantoprazole Sodium15$115
Doxycycline Hyclate18$96
Furosemide14$66
Prednisone22$52
Metoprolol Tartrate12$24

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →